
TY  - JOUR
TI  - 2016 ACR/ARHP Annual Meeting Abstract Supplement
JO  - Arthritis & Rheumatology
JA  - Arthritis & Rheumatology
VL  - 68
IS  - S10
SN  - 2326-5191
UR  - https://doi.org/10.1002/art.39977
DO  - doi:10.1002/art.39977
SP  - 1
EP  - 4550
PY  - 2016
AB  - For a searchable version of these abstracts, please visit www.acrabstracts.org.
ER  - 

AU  - Koduri, Priyadarshini
C7  - pp. 88-101
TI  - Preventive Issues for All Gravidas
SN  - 9781405192903
UR  - https://doi.org/10.1002/9781444317619.ch9
DO  - doi:10.1002/9781444317619.ch9
SP  - 88-101
KW  - preterm birth
KW  - primary prevention
KW  - prevention
PY  - 2016
AB  - Summary Primary preventive measures for preterm birth remain poorly studied, with few interventions known to be effective. Risk factors for preterm birth including medical conditions should be identified and addressed at the first prenatal visit. Additional useful measures include avoiding extremes of age, aiming for at least a 6 month inter-pregnancy interval and insisting on responsible assisted reproductive technology. Aiming for balanced nutrition and a healthy pre-pregnancy weight (> 120 lb or a BMI < 19 kg/m2) while avoiding a high protein diet is advisable. Daily folic acid supplementation for 1 year or longer prior to conception has been shown to reduce preterm birth risk and can be safely implemented. Moderate exercise regimens are safe in low risk women and bed rest should be discouraged. The work environment should be modified to avoid prolonged standing > 3 h/day, long work hours > 39 h/week and shift work. Douching, smoking, illicit drug and alcohol use should be discouraged. All women should be screened for domestic violence, sexually transmitted infections and asymptomatic bacteriuria.
ER  - 

TY  - JOUR
TI  - Abstracts of the 20th International Conference on Pharmacoepidemiology (ICPE) & Therapeutic Risk Management. Bordeaux, France, 22 - 25 August, 2004
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidem. Drug Safe.
VL  - 13
IS  - S1
SN  - 9781405192903
UR  - https://doi.org/10.1002/pds.987
DO  - doi:10.1002/pds.987
SP  - S1
EP  - S349
PY  - 2004
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 17
IS  - S3
SN  - 9781405192903
UR  - https://doi.org/10.1111/ajt.14305
DO  - doi:10.1111/ajt.14305
SP  - 205
EP  - 410
PY  - 2017
ER  - 

TY  - JOUR
TI  - Numbered abstracts, 001–398
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidem. Drug Safe.
VL  - 9
IS  - S1
SN  - 9781405192903
UR  - https://doi.org/10.1002/1099-1557(200008)9:1+<::AID-PDS523>3.0.CO;2-7
DO  - doi:10.1002/1099-1557(200008)9:1+<::AID-PDS523>3.0.CO;2-7
SP  - S1
EP  - S150
PY  - 2000
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 17
IS  - S2
SN  - 9781405192903
UR  - https://doi.org/10.1111/ajt.14155
DO  - doi:10.1111/ajt.14155
SP  - 11
EP  - 92
PY  - 2017
ER  - 

TY  - JOUR
TI  - TSANZ Abstracts
JO  - Respirology
VL  - 10
IS  - s1
SN  - 9781405192903
UR  - https://doi.org/10.1111/j.1440-1843.2005.00663.x-i1
DO  - doi:10.1111/j.1440-1843.2005.00663.x-i1
SP  - A8
EP  - A94
PY  - 2005
ER  - 

TY  - JOUR
TI  - SARS abstracts
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 104
IS  - S3
SN  - 9781405192903
UR  - https://doi.org/10.1002/bjs.10531
DO  - doi:10.1002/bjs.10531
SP  - 7
EP  - 57
PY  - 2017
ER  - 

TY  - JOUR
TI  - 2017 ACR/ARHP Annual Meeting Abstract Supplement
JO  - Arthritis & Rheumatology
JA  - Arthritis & Rheumatology
VL  - 69
IS  - S10
SN  - 9781405192903
UR  - https://doi.org/10.1002/art.40321
DO  - doi:10.1002/art.40321
SP  - 1
EP  - 4481
PY  - 2017
AB  - Abstract For a searchable version of these abstracts, please visit www.acrabstracts.org.
ER  - 

C7  - pp. 1121-1152
TI  - Index
SN  - 9781405184762
UR  - https://doi.org/10.1002/9781444345100.index
DO  - doi:10.1002/9781444345100.index
SP  - 1121-1152
PY  - 2017
ER  - 

TY  - JOUR
TI  - Oral Presentations
JO  - Journal of Obstetrics and Gynaecology Research
JA  - J. Obstet. Gynaecol. Res.
VL  - 41
IS  - S1
SN  - 9781405184762
UR  - https://doi.org/10.1111/jog.12872
DO  - doi:10.1111/jog.12872
SP  - 6
EP  - 93
PY  - 2015
ER  - 

TY  - JOUR
TI  - Tissue Engineering and Regenerative Medicine
JO  - Journal of Tissue Engineering and Regenerative Medicine
VL  - 6
IS  - s1
SN  - 9781405184762
UR  - https://doi.org/10.1002/term.1586
DO  - doi:10.1002/term.1586
SP  - 1
EP  - 429
PY  - 2012
ER  - 

TY  - JOUR
TI  - ASGBI abstracts 2007 Poster presentations
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 94
IS  - S2
SN  - 9781405184762
UR  - https://doi.org/10.1002/bjs.5851
DO  - doi:10.1002/bjs.5851
SP  - 79
EP  - 198
PY  - 2007
AB  - Abstract The Annual Scientific Meeting of the Association of Surgeons of Great Britain and Ireland takes place this year at Manchester Central (18th - 20th April 2007), under the presidency of Professor Brian J Rowlands. To view all abstracts of poster presentations from this meeting, please click the pdf link on this page.
ER  - 

TY  - JOUR
TI  - Posters
JO  - Journal of Digestive Diseases
JA  - Journal of Digestive Diseases
VL  - 18
IS  - S1
SN  - 9781405184762
UR  - https://doi.org/10.1111/1751-2980.12518
DO  - doi:10.1111/1751-2980.12518
SP  - 15
EP  - 159
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Haemophilia
JA  - Haemophilia
VL  - 24
IS  - S5
SN  - 9781405184762
UR  - https://doi.org/10.1111/hae.13478
DO  - doi:10.1111/hae.13478
SP  - 3
EP  - 196
PY  - 2018
ER  - 

TY  - JOUR
TI  - Oral Full Papers
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 100
IS  - s7
SN  - 9781405184762
UR  - https://doi.org/10.1002/bjs.9231
DO  - doi:10.1002/bjs.9231
SP  - 1
EP  - 53
PY  - 2013
ER  - 

TY  - JOUR
TI  - Hepatology Clinical
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 32
IS  - S2
SN  - 9781405184762
UR  - https://doi.org/10.1111/jgh.13893
DO  - doi:10.1111/jgh.13893
SP  - 87
EP  - 115
PY  - 2017
ER  - 

TY  - JOUR
TI  - American College of Clinical Pharmacy
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 23
IS  - 10
SN  - 9781405184762
UR  - https://doi.org/10.1592/phco.23.12.1327.32698
DO  - doi:10.1592/phco.23.12.1327.32698
SP  - 1327
EP  - 1374
PY  - 2003
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - APMIS
VL  - 117
IS  - s127
SN  - 9781405184762
UR  - https://doi.org/10.1111/j.1600-0463.2009.02504.x
DO  - doi:10.1111/j.1600-0463.2009.02504.x
SP  - 67
EP  - 180
PY  - 2009
ER  - 

TY  - JOUR
AU  - Ng, B. J. H.
AU  - Lindstrom, S.
TI  - Study of compliance with a clinical pathway for suspected pulmonary embolism
JO  - Internal Medicine Journal
VL  - 41
IS  - 3
SN  - 9781405184762
UR  - https://doi.org/10.1111/j.1445-5994.2009.02134.x
DO  - doi:10.1111/j.1445-5994.2009.02134.x
SP  - 251
EP  - 257
KW  - emergency service
KW  - hospital/standard
KW  - guideline adherence
KW  - pulmonary embolism/diagnosis
KW  - retrospective study
PY  - 2011
AB  - Abstract Background/Aims: Clinical pathways to guide the investigation of suspected pulmonary embolism have been increasingly adopted by emergency departments worldwide. This study evaluated the compliance with a clinical pathway that combines risk assessment (Wells score) with d-dimer, ventilation?perfusion scanning or computed tomographic pulmonary angiography (CTPA). The aims of this study were to identify factors that contribute to compliance and to assess patient outcomes and resource utilization. Methods: Repeated retrospective chart reviews of 239 patients who underwent investigation for pulmonary embolism through our emergency department extracted patient demographics, pathway parameters and patient outcomes. A phone interview at 3-month follow up was carried out. Results: Incidence of pulmonary embolism was 8.4% (n= 20). Compliance to the clinical pathway occurred in 120 subjects (50.2%). Non-compliance occurred in 71 subjects (29.7%). Forty-eight subjects (20.1%) underwent risk assessments, but subsequent diagnostic tests did not conform to the stated pathway (partial compliance). Compliance was poor in subjects assessed by non-emergency department doctors (?2= 27.95, P≤ 0.001). Compliance occurred less in pregnant subjects (?2= 7.27, P= 0.007) and those with chronic respiratory disease (?2= 5.31, P= 0.021). Subjects in the compliant group were less likely to undergo CTPA (odds ratio 2.07 (1.16?3.70), P= 0.012). Conclusions: Compliance with this clinical pathway allowed emergency department doctors in an Australian university teaching hospital to complete diagnostic testing for suspected pulmonary embolism appropriately unless non-emergency department doctors became involved. Compliance with this pathway altered the distribution of diagnostic tests performed with less reliance on CTPA, but was not associated with better patient outcomes.
ER  - 
